GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer
Clinical trial NCT02983604 · TERMINATED
Trial details
- NCT number
- NCT02983604
- Sponsor
- Gilead Sciences
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-10
- Primary completion
- 2018-07-19
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.